What is the current Price Target for the Petros Pharmaceuticals Inc stock?

The average Petros Pharmaceuticals Inc target price is $1.00. This is 1,359.85% higher than the current stock price. 1 Analyst has issued a Petros Pharmaceuticals Inc price target 2026.

How high will the Petros Pharmaceuticals Inc stock rise?

No reliable answer can be given as to how high the Petros Pharmaceuticals Inc stock will rise. The performance of stocks, including the Petros Pharmaceuticals Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Petros Pharmaceuticals Inc stock today?

The performance of Petros Pharmaceuticals Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Petros Pharmaceuticals Inc stock fall?

The decline in Petros Pharmaceuticals Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Petros Pharmaceuticals Inc Forecast, price target & analysts

$0.07

3.94% today

Nasdaq, Apr 04, 09:20 pm CET

ISIN

US71678J1007

Symbol

PTPI

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Petros Pharmaceuticals Inc Target price 2025 - Analyst rating & recommendation

Petros Pharmaceuticals Inc Classifications & Recommendation:

Buy

100%

Petros Pharmaceuticals Inc Price Target

Target Price	$1.00
Price	$0.07
Potential	1,359.85% register free of charge
Number of Estimates	1

	1 Analyst has issued a Petros Pharmaceuticals Inc price target 2026. The average Petros Pharmaceuticals Inc target price is $1.00. This is 1,359.85% register free of charge higher than the current stock price.
	A rating was issued by 1 analysts: 1 Analysts recommend Petros Pharmaceuticals Inc to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Petros Pharmaceuticals Inc stock has an average upside potential 2026 of 1,359.85% register free of charge . Most analysts recommend the Petros Pharmaceuticals Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Revenue Million $	5.11	5.48
	12.20%	7.14%

1 Analyst has issued a sales forecast Petros Pharmaceuticals Inc 2025 . The average Petros Pharmaceuticals Inc sales estimate is

Unlock

. This is

Unlock

than the revenue of the last 12 months(TTM). The highest sales forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics:

2024	$5.1m	12.20%
2025	$5.5m 7.14% Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
EV/Sales		0.81

Based on analysts' sales estimates for 2025, the Petros Pharmaceuticals Inc stock is valued at an EV/Sales of

Unlock

and an P/S ratio of

Unlock

This results in the following potential growth metrics and future valuations:

Current	1.12	231.76%
2025	0.81 27.92% Unlock

Current	0.40	14.09%
2025	0.57 42.50% Unlock

Petros Pharmaceuticals Inc...

Discover more stocks with a high price target

Novo Nordisk 83.92%

Coinbase Global, Inc. 83.53%

BioNTech SE - ADR 50.09%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now